Sign in
4

Changes in Ownership

Enveric Biosciences, Inc. Filed Acc 0000921895-17-001277

Director gave up 3,683 shares (to pay taxes)

  • Director acquired 200 shares (code L)
  • Director acquired 10,522 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Eberwein Jeffrey E. Director 2017-04-17 Other acquisition +170 $6.51 $1,107 83,278 I
Eberwein Jeffrey E. Director 2017-04-19 Other acquisition +2 $6.51 $13 83,280 I
Eberwein Jeffrey E. Director 2017-04-21 Other acquisition +23 $6.51 $150 83,303 I
Eberwein Jeffrey E. Director 2017-04-28 Other acquisition +5 $6.51 $33 83,308 I
Eberwein Jeffrey E. Director 2017-05-01 Option exercise +10,522 30,749 D
Eberwein Jeffrey E. Director 2017-05-01 Shares withheld for taxes −3,683 $6.59 $24,271 27,066 D
Derivatives
Eberwein Jeffrey E. Director 2017-05-01 Option exercise · Restricted Stock Unit +10,522 0 D
Loading xslF345X03/form410211002c_05032017.xml…